Adverse effect of oth fibrinolysis-affecting drugs, sequela

This code signifies a long-term or residual condition resulting from an adverse reaction to a medication that affects the breakdown of blood clots, other than specific categories like anticoagulants or antiplatelet drugs. These sequelae are persistent health problems that arose after the initial adverse drug event has resolved.

Use this code when documenting a chronic or permanent condition directly attributable to a past adverse effect from a fibrinolysis-affecting drug. This applies when the acute adverse event is no longer present, but its lasting consequences require ongoing management. Examples include chronic organ damage or persistent neurological deficits.

• Always assign this code as a secondary diagnosis, following the code for the specific sequela (e.g., chronic kidney disease).
• Ensure documentation clearly links the current condition to a past adverse effect of a fibrinolysis-affecting drug.
• Verify that the drug involved is not an anticoagulant (T45.5-) or antiplatelet (T45.7-) to ensure correct category selection.